Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice

Cancer

Volumn 116, Issue 16, 2010, Pages 3862-3874

  Barnett Jr , Carlton C ^a,b   Beck, Adam W ^c   Holloway, Shane E ^d   Kehler, Marguerite ^e   Schluterman, Marie K ^b,d   Brekken, Rolf A ^b,d   Fleming, Jason B ^f   Silliman, Christopher C ^a,e,g  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Bonfils Blood Center   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF COLORADO   (United States)

Author keywords

Erythrocytes; Immunomodulation; Metastasis; Pancreatic cancer; Proliferation; Transfusion

Indexed keywords

ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SIZE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; IMMUNOCOMPETENCE; IN VITRO STUDY; LEUKOCYTE; LIVER METASTASIS; LYMPH NODE METASTASIS; MORBIDITY; MOUSE; NONHUMAN; PANCREAS CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; ANIMAL; BLOOD COMPONENT THERAPY; BLOOD STORAGE; CELL MOTION; CHEMISTRY; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PANCREAS TUMOR; PATHOLOGY; PERITONEUM TUMOR; PLASMA; SECONDARY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; INJECTIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MICE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PLASMA; IN VITRO TECHNIQUES;

EID: 77956790922     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25140     Document Type: Article

References (52)

1. Opelz G, Terasaki P. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978;299:799-803. (Pubitemid 9044523)
2. Gantt CL. Red blood cells for cancer patients. Lancet. 1981;2:363.
3. Dionigi G, Rovera F, Boni L, et al. The impact of perioperative blood transfusion on clinical outcomes in colorectal surgery. Surg Oncol. 2007;16(suppl 1):177-182. (Pubitemid 350198902)
4. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 1995;35:760-768.
5. Blumberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusion of whole blood and recurrence of cancer. BMJ. (Clin Res Ed). 1986;293:530-533.
6. Wobbes T, Joosen KH, Kuypers HH, Beerthuizen GI, Theeuwes GM. The effect of packed cells and whole blood transfusions of survival after curative resection for colorectal carcinoma. Dis Colon Rectum. 1989;32:743-748. (Pubitemid 19215923)
7. Blumberg N, Chuang-Stein C, Heal JM. The relationship of blood transfusion, tumor staging, and cancer recurrence. Transfusion. 1990;30:291-294. (Pubitemid 20180818)
8. Busch OR, Hop WC, Hoynick van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993;328:1372-1376. (Pubitemid 23131389)
9. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994;84:1705-1721.
10. Busch OR, Hop WC, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg Oncol. 1994;220:791-797.
11. Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev. 2002;16:304-314.
12. Sene A, Jeacock J, Robinson C, Walsh S, Kingston RD. Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer. Ann R Coll Surg Eng. 1993;75:261-267. (Pubitemid 23212050)
13. Francis DM. Relationship between blood transfusion and tumour behaviour. Br J Surg. 1991;78:1420-1428.
14. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med. 1994;118:371-379.
15. Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important? Dis Colon Rectum. 1990;33:127-130.
16. Mynster T, Nielsen HJ; Danish RANX05 Colorectal Cancer Study Group. Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum. 2001;44:955-964.
17. Yeh JJ, Gonene M, Tomlinson JS, Idrees K, Brennan MF, Fong Y. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg. 2007;94:466-472.
18. Park SJ, Kim SW, Jang JY, Lee KU, Park YH. Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy? World J Surg. 2002;26:487-492.
19. Shanwell A, Kristiansson M, Remberger M, Ringden O. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion. 1997;37:678-684.
20. Kristiansson M Soop M, Saraste L, Sundqvist KG. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand. 1996;40:496-501.
21. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124:684-694.
22. Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 2002;283:C1592-C1603.
23. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458-1467.
24. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454-462.
25. Kao K. Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects. Transfus Med Rev. 2000;14:12-22.
26. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion. 1999;39:701-710.
27. Technical Manual. 15th ed. Bethesda, Md: American Association of Blood Banks; 2003.
28. Technical Manual. 14th ed. Bethesda, Md: American Association of Blood Banks; 2002.
29. Holloway S, Davis M, Jaber R, Fleming, J. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway. Int J Gastrointest Cancer. 2003;33:61-69.
30. Animal Resources Body Weight Study of 1993. Bar Harbor, Me: The Jackson Laboratory; 1993.
31. Fleming JB, Shen GL, Holloway SE, Davis M, Brekken RA. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy. Mol Cancer Res. 2005;3:413-423.
32. Fleming J, Brekken RA. Functional imaging of angiogenesis in an orthotopic model of pancreatic cancer. J Cell Biochem. 2003;90:492-501.
33. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 2004.
34. Dineen SP, Roland CL, Toombs JE, Kelher M, Silliman CC, Brekken RA, Barnett CC Jr. The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res. 2009;153:132-137.
35. Neilsen HJ, Reimert CM, Pedersen AM, et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion. 1996;36:960-965.
36. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood. 1993;81:1880-1882.
37. Dzik S, Mincheff M, Puppo F. Apoptosis, transforming growth factor-beta, and the immunosuppressive effect of transfusion. Transfusion. 2002;42:1221-1223.
38. Biffl WL, Carnaggio R, Moore EE, Ciesla DJ, Johnson JL, Silliman CC. Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. Surgery. 2003;134:86-91.
39. Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ, Silliman CC. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: abrogation by poststorage washing but not prestorage leukoreduction. J Trauma. 2001;50:426-431; discussion 432.
40. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg. 2002;137:711-716; discussion 716-717.
41. Bordin JO, Blajchman MA. Blood Transfusion and tumor growth in animal models. In: Vamvakas E, Blajchman MA, eds. Immunomodulatory Effects of Blood Transfusion. Bethesda, Md: American Association of Blood Banks; 1997.
42. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating- factor receptor. Vox Sang. 1992;63:133-136.
43. Silliman CC, Johnson CA, Clay KL, Thurman GW, Ambruso DR. Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids. 1993;28:415-418.
44. Vamvakas EC, Blajchman MA. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Transfus Med Rev. 2000;14:23-33.
45. Murata N, Idezuki Y, Konishi T, et al. Influence of perioperative blood transfusion on the prognosis of patients with gastric cancer receiving anticancer chemotherapy. Gastric Cancer. 2000;3:24-27.
46. Adamson JW. New blood, old blood, or no blood? N Engl J Med. 2008;358:1295-1296.
47. Aiboshi J, Moore EE, Ciesla DJ, Silliman CC. Blood transfusion and the two-insult model of post-injury multiple organ failure. Shock. 2001;15:302-306.
48. Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997;37:719-726.
49. Bordin JO, Chiba AK, Carvalho KIL, et al. The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients. Transfusion. 1999;39:718-723.
50. Nakatsuka A, Yamaguchi K, Shimizu S, et al. Positive washing cytology in patients with pancreatic cancer indicates a contraindication of pancreatectomy. Int J Surg Investig. 1999;1:311-317.
51. Silliman CC, Bjornsen AJ, Wyman TH, Kelher M, Allard J, Bieber S, Voelkel NF. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43:633-640.
52. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med. 2006;34(suppl 5):S124-S131.